Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy

Clinical trial NCT07409298 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07409298
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

CDK4/6 Inhibitors Depression Anxiety Disorder Breast Cancer

Start date: 2025-07-05
Primary completion: 2026-05-24
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.